Abstract
The expression of p53 was studied immunohistochemically in combination with the DNA ploidy pattern by gland isolation in 97 alcohol-fixed gastric lesions. A polyclonal antibody, CM-1, was applied to the paraffin-embedded sections in this study. Overexpression of the p53 protein was found in 73.2% of 41 well or moderately differentiated gastric carcinomas and 52.2% of 23 cases with poor differentiation (P<0.05). Immunoreactivity of p53 was also detected in isolated cancerous glands. No p53 immunoreactivity was detected in benign gastric lesions including adenomas, hyperplastic polyps and regions of intestinal metaplasia. In addition, flow cytometric DNA analysis was performed on isolated glandular epithelium adjacent to the portions used for immunostaining. DNA aneuploidy (DA) was detected in 85.7% of the well or moderately differentiated carcinomas and 42.9% of those with poor differentiation (P<0.05). There was a positive correlation between DA, p53 positivity and the presence of regional lymph node metastasis, but not with other clinicopathological variables. In spite of the limited applicability of this method to poorly differentiated gastric cancer, we found that immunostaining and flow cytometry in combination with the gland isolation method facilitates analysis of gastric carcinogenesis.
Similar content being viewed by others
References
Arai T, Kino I (1989) Morphometrical and cell kinetics studies of normal human colorectal mucosa. Acta Pathol Jpn 39:725–730
Banks L, Matlashewski G, Crawford L (1986) Isolation of human p53 specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529–534
Bartec J, Barcova J, Vojtesk B, Staskova Z (1990) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703
Bjerknes M, Cheng H (1981) Method for the isolation of intact epithelium from the mouse intestine. Anat Rec 199:565–574
Cheng H, Bjerknes M, Amar J (1984) Method for determination of epithelial kinetic parameters of human colonic epithelium isolated from surgical and biopsy specimens. Gastroenterology 86:78–85
Fisher CJ, Gillet CE, Vojtesk B, Millis RR (1994) Problem with p53 immunohistochemical staining: the effect of fixation and variation in the method of evaluation. Br J Cancer 69:26–31
Harris CC, Holstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327
Hiyoshi H, Matsuno Y, Kato H, Shimosato Y, Hirohashi S (1992) Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 83:101–106
Igarashi H, Sugimura H, Maruyama K, Kitayama Y, Ohta I, Suzuki M, Tanaka M, Dobashi Y, Kino I (1994) Alteration of immunoreactivity by hydrated autoclaving, microwave treatment, and simple heating of paraffin-embedded tissue sections. APMIS 102:295–307
Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S (1990) Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 85:835–840
Janet M, Bruner JH, Saya CH (1993) p53 protein immunostaining in routinely processed paraffin-embedded sections. Mod Pathol 6:189–193
Japanese Research Society for Gastric Cancer (1993) The general rules for gastric cancer study, 12th edn. Kanehara, Tokyo, pp 42–75
Joypaul VB, Newman LE, Hopwood D, Grant A, Quershi S, Lane DP, Cuschieri A (1993) Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study. J Pathol 170:279–283
Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, Sugimachi K (1993) Gastric cancer with p53 overexpression has high potential for metastasis to lymph nodes. Br J Cancer 67:589–593
Kitayama Y, Nakamura S, Sugimura H, Kino I (1995) Cytophotometric and flow cytometric DNA content of isolated glands in gastric neoplasia. Gut 36:516–521
Lane DP, Benchimol S (1980) p53 oncogene or anti-oncogene. Genes Dev 4:1–8
Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona R (1993) p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 88:1916–1920
Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859–862
Nakamura S, Goto J, Kitayama Y, Kino I (1994) Application of the crypt-isolation technique to flow cytometry analysis of DNA content in colorectal neoplasms. Gastroenterology 106:100–107
Ochi H, Douglas OH, Sandberg AA (1986) Cytogenetic studies in primary gastric cancer. Cancer Genet Cytogenet 22:295–307
Renault B, Broek M, Fodde R, Wijnen J, Pellegata SM, Amadori D, Khan MP, Ranzani NG (1993) Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614–2617
Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura U, Kajiyama G, Tahara E (1991) Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 51:2926–2931
Sasano H, Miyazaki S, Gooukon U, Nishihira T, Sawai T, Nagura H (1992) Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating nuclear antigen expression. Hum Pathol 23:1238–1243
Sasano H, Date F, Imatani A, Asaki S, Nagura H (1993) Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol 24:584–589
Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P (1991) p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 63:317–319
Starzynska T, Bromey M, Ghosh A, Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66:558–562
Tamura G, Kihara T, Nomura K, Terada M, Sugimura T, Hirohashi S (1991) Detection of frequent p53 gene mutation in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 51:3056–3058
Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S (1993) p53 mutation in gastric and colorectal cancer. Int J Cancer 54:759–764
Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T, Terada M (1993) p53 gene mutation in gastric cancer metastasis and gastric cancer cell lines derived from metastasis. Cancer Res 51:5800–5805
Yonemura Y, Fushida S, Tsugawa K, Ninomiya I, Fonseca L, Yamaguchi A, Miyazaki I, Urano T, Shiku H (1993) Correlation of p53 expression and proliferative activity in gastric cancer. Anal Cell Pathol 5:277–288
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitayama, Y., Sugimura, H., Tanaka, M. et al. Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method. Vichows Archiv A Pathol Anat 426, 557–562 (1995). https://doi.org/10.1007/BF00192109
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00192109